COVID-19 vaccines have demonstrated efficacy in reducing hospitalizations and mortality rates. However, their effectiveness in lowering the occurrence of cardiopulmonary events in a high-risk population for cardiovascular issues...
Most Recent Articles
Atrial Fibrillation and Thromboembolic Risks: Insights from a Population-Based Study
In a population-based cohort study utilizing electronic healthcare records from over 5 million primary care patients in the UK from 2005 to 2020, the association between atrial fibrillation (AF) and thromboembolic outcomes...
Facial Infrared Thermography and Machine Learning for Predicting Coronary Artery Disease
In a recent study, researchers investigated the potential of using facial infrared thermography (IRT) combined with machine learning for predicting coronary artery disease (CAD). The study enrolled 460 participants referred for...
AI-Driven Digital Lifestyle Coaching for Hypertension Management: A 24-Week Trial
In a single-arm nonrandomized trial, the effectiveness of a fully digital, autonomous, and artificial intelligence (AI)–based lifestyle coaching program on achieving blood pressure (BP) control among adults with hypertension was...
Impact of Early vs Late DOAC Initiation on Ischemic Stroke Outcomes in Atrial Fibrillation: Insights from the ELAN Trial Analysis
In a post hoc analysis of the Early Versus Later Anticoagulation for Stroke With Atrial Fibrillation (ELAN) trial involving 1962 participants, the safety and efficacy of early vs late initiation of direct oral anticoagulation...